- Home
- AVIR vs API Comparison
AVIR vs API Comparison
Compare AVIR & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- API
- Stock Information
- Founded
- AVIR 2012
- API 2013
- Country
- AVIR United States
- API United States
- Employees
- AVIR N/A
- API N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- API Computer Software: Prepackaged Software
- Sector
- AVIR Health Care
- API Technology
- Exchange
- AVIR Nasdaq
- API Nasdaq
- Market Cap
- AVIR 290.4M
- API 342.9M
- IPO Year
- AVIR 2020
- API 2020
- Fundamental
- Price
- AVIR $3.14
- API $3.99
- Analyst Decision
- AVIR Hold
- API Strong Buy
- Analyst Count
- AVIR 1
- API 1
- Target Price
- AVIR $6.00
- API $6.00
- AVG Volume (30 Days)
- AVIR 399.6K
- API 398.8K
- Earning Date
- AVIR 11-06-2025
- API 11-24-2025
- Dividend Yield
- AVIR N/A
- API N/A
- EPS Growth
- AVIR N/A
- API N/A
- EPS
- AVIR N/A
- API N/A
- Revenue
- AVIR N/A
- API $133,554,000.00
- Revenue This Year
- AVIR N/A
- API $7.20
- Revenue Next Year
- AVIR N/A
- API $11.26
- P/E Ratio
- AVIR N/A
- API N/A
- Revenue Growth
- AVIR N/A
- API N/A
- 52 Week Low
- AVIR $2.46
- API $2.53
- 52 Week High
- AVIR $4.02
- API $6.99
- Technical
- Relative Strength Index (RSI)
- AVIR 52.91
- API 55.50
- Support Level
- AVIR $2.78
- API $3.76
- Resistance Level
- AVIR $2.94
- API $4.02
- Average True Range (ATR)
- AVIR 0.10
- API 0.17
- MACD
- AVIR 0.04
- API 0.01
- Stochastic Oscillator
- AVIR 90.79
- API 71.25
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.